KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sarepta Therapeutics (SRPT) Non Operating Income (2016 - 2025)

Sarepta Therapeutics has reported Non Operating Income over the past 15 years, most recently at -$5.3 million for Q4 2025.

  • Quarterly results put Non Operating Income at -$5.3 million for Q4 2025, down 152.93% from a year ago — trailing twelve months through Dec 2025 was -$2.4 million (down 105.72% YoY), and the annual figure for FY2025 was -$2.4 million, down 105.72%.
  • Non Operating Income for Q4 2025 was -$5.3 million at Sarepta Therapeutics, down from $48.0 million in the prior quarter.
  • Over the last five years, Non Operating Income for SRPT hit a ceiling of $301.1 million in Q4 2023 and a floor of -$83.1 million in Q1 2025.
  • Median Non Operating Income over the past 5 years was $3.0 million (2022), compared with a mean of $14.2 million.
  • Biggest five-year swings in Non Operating Income: plummeted 4077.59% in 2022 and later skyrocketed 5347.35% in 2023.
  • Sarepta Therapeutics' Non Operating Income stood at -$16.1 million in 2021, then surged by 134.38% to $5.5 million in 2022, then skyrocketed by 5347.35% to $301.1 million in 2023, then crashed by 96.66% to $10.1 million in 2024, then tumbled by 152.93% to -$5.3 million in 2025.
  • The last three reported values for Non Operating Income were -$5.3 million (Q4 2025), $48.0 million (Q3 2025), and $38.1 million (Q2 2025) per Business Quant data.